Efficacy and Safety of Sotagliflozin Versus Placebo in Patients With Type 2 Diabetes Mellitus on Background of Metformin

NCT02926950 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

518

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Sotagliflozin (SAR439954)
DRUG: Placebo
DRUG: Metformin

Sponsor

Lexicon Pharmaceuticals

Collaborators

[object Object]